The advent of new breeding techniques (NBTs) and in particular genome editing (GEd), has provided more accurate and precise ways to introduce targeted changes in the genome of both plants and animals. This has resulted in use of the technology by a wider variety of stakeholders for different applications in comparison to transgenesis. Regulators in different parts of the world are now examining their current frameworks to assess their applicability to these NBTs and their products. We looked at how countries selected from a sample of geographical regions globally are currently handling applications involving GEd organisms as well as what they foresee as opportunities and potential challenges to acceptance of the technology in their jurisdictions. In addition to regulatory frameworks that create an enabling environment for these NBTs, acceptance of the products by the public is vitally important. We therefore suggest that early stakeholder engagement and communication to the public is emphasized to foster public acceptance even before products are ready for market. Further, global co-operation and consensus on issues cutting across regions will be crucial in avoiding regulatory-related bottlenecks that affect global trade and agriculture.
|Journal||Frontiers in Bioengineering and Biotechnology|
|Early online date||30 Sep 2022|
|Publication status||Published - 30 Sep 2022|
- genetic modification
- genome editing
- new breeding techniques
- regulatory frameworks